Lannett adds Silarx's liquid manufacturing to its operations

Philadelphia-based generic maker Lannett says it has beefed up its manufacturing, and its generic portfolio, with the acquisition of Silarx for an undisclosed amount. Silarx specializes in liquid products, both generic prescriptions and over-the-counter, which it manufactures at its 110,000-square-foot facility in Carmel, NY. "Upon closing, the acquisition will add a high quality, talented research team and manufacturing capacity," Lannett CEO Arthur Bedrosian said in a statement. Release